Related Experiment Video
Updated: Jul 9, 2026

Improving IV Insulin Administration in a Community Hospital
Published on: June 11, 2012
Structured, person-centred glycaemic optimisation before surgery: The Manchester IP3D experience
Mohammed So Ahmed1, Mariyah Ahmed1, Adhithya Sankar2
1Diabetes, Endocrine and Metabolism Centre, Manchester Royal Infirmary, Manchester University Hospitals NHS Foundation Trust/University of Manchester, Manchester, UK.
Study Objective:
To evaluate the impact of a diabetes specialist nurse (DSN)-led perioperative optimisation service on glycaemic control in adults undergoing elective surgery.
Design:
Retrospective service evaluation.
Setting:
Manchester Royal Infirmary (Manchester University NHS Foundation Trust), a large UK teaching hospital and regional specialist centre.
Participants:
398 adults with diabetes (mean age 62.2 years; 76.3% type 2 diabetes) referred to the preoperative pathway between 2020 and 2024.
Interventions:
A structured pathway involving DSN-led outpatient consultations, blood result monitoring, and targeted education to support self-management and guideline adherence.
Main Outcome Measure(S):
Change in HbA1c from referral to the perioperative period (within 12 weeks of surgery) and predictors of glycaemic improvement.
Results:
Participants had a median baseline HbA1c of 75 mmol/mol. Over a median 16-week interval with two DSN contacts, HbA1c decreased by a median of 18 mmol/mol. Multivariable analysis identified higher baseline HbA1c (p < 0.001) and frequency of DSN contacts (p < 0.001) as independent predictors of improvement. Notably, medication intensification and diabetes technology use were not significantly associated with HbA1c reduction.
Conclusions:
A structured DSN-led pathway achieves clinically meaningful HbA1c reductions in high-risk surgical patients. These gains were associated with specialist engagement rather than complex medication adjustments, suggesting that focused education is a safe, effective strategy for perioperative optimisation that minimises pharmacological burden in the secondary care setting.
Related Concept Videos
Diabetes: Management and Pharmacotherapy
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Hypoglycemia and Glucagon
SBAR II: Application of SBAR
SBAR Report from a Nurse to a Health Care Provider
S: "Hello, Dr. Smith. This is Jane, RN, from the Med Surg unit. I am calling to tell you about Ms. White in Room 210, who is experiencing increased pain and redness at her incision site. Her recent...
Diabetes Mellitus: Type 2 and Gestational
Chronic Pancreatitis II: Collaborative Care
Assessment:
Oral Hypoglycemic Agents: Biguanides and Glitazones